Johnson & Johnson (JNJ) EBITDA margin US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 33.3% | 39.3% | 23.1% | 34.0% | 27.9% | 35.6% | ||
Changes by years, y/y, % | +4pp | +6pp | -16pp | +11pp | -6pp | +0.2% |
Johnson & Johnson. EBITDA margin, %
Johnson & Johnson. EBITDA margin, changes, pp
Johnson & Johnson (JNJ) EBITDA margin US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | 37.1% | 40.4% | 37.8% | 31.6% | 32.7% | 35.6% | |
Changes by years, y/y, % | +2pp | +5pp | -3pp | -7pp | -6pp | |||
Changes by quarters, q/q, % | +5pp | +3pp | -3pp | -6pp | +1pp |